OnKure Therapeutics, Inc.OKUREarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Deep AnalysisCompare

OnKure Therapeutics, Inc. is a clinical-stage biotechnology company specializing in precision oncology therapy development. It focuses on creating targeted small molecule drugs including epigenetic and kinase inhibitors, to address unmet medical needs for patients with hard-to-treat solid tumors and hematologic cancers, serving global oncology patient segments.